Strengthen onboarding, sustain long-term engagement, and keep patients confident in across connected diabetes devices in their care journey.
Diabetes device companies support patients who rely on their devices every day. These devices include continuous glucose monitors (CGMs), insulin pumps, automated insulin delivery (AID) systems, and connected diabetes management platforms. Patients interact with them many times each day. Because of this, the relationship between the patient and the device is critical. When onboarding is confusing, connectivity fails, supplies are delayed, or questions go unanswered, patients lose confidence. These problems can reduce adherence and increase health risks. At scale, poor support can weaken clinical outcomes and damage a device’s reputation in the market.
Ameridial supports diabetes device companies with empathy-trained teams and AI-powered quality monitoring. Our teams assist with patient onboarding and device activation. We also provide help with app pairing, connectivity troubleshooting, and supply reorder coordination. In addition, we handle device support within approved non-clinical boundaries, adverse event intake, recall notifications, and remote monitoring support. This approach helps device manufacturers provide reliable patient assistance. As a result, patients stay engaged with their devices and maintain long-term adherence.
Guide new patients through account creation, device registration, and activation. This helps reduce setup friction and improves early device adoption.
Help patients with app pairing, Bluetooth connectivity, sensor setup, and account access. Resolve common connection issues within approved non-clinical support boundaries.
Manage supply reorders, shipment updates, and subscription plans. This helps prevent gaps in sensors, infusion sets, and other consumables.
Provide support for error alerts, device operation questions, and common technical issues. Escalate complex cases through defined protocols when needed.
Conduct follow-up outreach such as device usage check-ins, reminders, and engagement support. These efforts help reduce early device abandonment.
Capture adverse event or device malfunction reports. Document details accurately and route them through approved escalation workflows for regulatory reporting.
Manage recall and safety notifications for affected patients and providers. Deliver compliant communications within required regulatory timelines.
Deep diabetes device domain familiarity
No. Ameridial provides non-clinical administrative and technical support only. Our teams do not offer clinical guidance, dosing advice, or medical recommendations. All clinical decisions remain with the patient’s physician and diabetes care team.
Yes. Ameridial supports onboarding for CGM sensors, transmitters, insulin pumps, and automated insulin delivery (AID) systems. Our teams guide patients through account setup, device registration, app pairing, and activation using manufacturer-approved workflows.
Ameridial captures adverse event and device malfunction reports from patients and clinicians. Our teams document the case details and route them through approved escalation workflows to support FDA MedWatch and medical device reporting requirements.
Yes. Ameridial can scale quickly to support new device launches. We prepare trained teams, approved scripts, and quality monitoring workflows before launch to manage patient contact volume from day one.
Still have questions?
Schedule a consultation with our team.
© 2026 Ameridial Inc. – the nation’s leading healthcare contact center. All Rights Reserved.